Stockreport

TG Therapeutics: BRIUMVI Development Could Lead To Great Results [Seeking Alpha]

TG Therapeutics, Inc.  (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF The company has strong barriers to entry and patent protection for BRIUMVI, allowing for potential growth in 2024 and 2025. Hedge funds have started reinvesting in TG [Read more]